130 related articles for article (PubMed ID: 949171)
1. Activity of sulfamethoxazole and trimethoprim against Bacteroides fragilis.
Phillips I; Warren C
Antimicrob Agents Chemother; 1976 May; 9(5):736-40. PubMed ID: 949171
[TBL] [Abstract][Full Text] [Related]
2. Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates.
Jackson-York GL; Gump BB; Gump DW
J Antimicrob Chemother; 1983 Nov; 12(5):515-8. PubMed ID: 6671927
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
Crider SR; Colby SD
Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
[TBL] [Abstract][Full Text] [Related]
4. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria.
Rosenblatt JE; Stewart PR
Antimicrob Agents Chemother; 1974 Jul; 6(1):93-7. PubMed ID: 15828176
[TBL] [Abstract][Full Text] [Related]
5. Activity of sulfamethoxazole trimethoprim against Bacteroides fragilis.
Nadaud M
Zentralbl Bakteriol Orig A; 1978 Nov; 242(1):79-84. PubMed ID: 735555
[TBL] [Abstract][Full Text] [Related]
6. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
Najjar A; Murray BE
Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of anaerobes to co-trimoxazole.
Wüst J
Infection; 1980; 8 Suppl 2():S187-9. PubMed ID: 7450860
[TBL] [Abstract][Full Text] [Related]
8. The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.
Vilchèze C; Jacobs WR
Antimicrob Agents Chemother; 2012 Oct; 56(10):5142-8. PubMed ID: 22825115
[TBL] [Abstract][Full Text] [Related]
9. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.
Hammerschlag MR
Rev Infect Dis; 1982; 4(2):500-5. PubMed ID: 6981168
[TBL] [Abstract][Full Text] [Related]
10. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.
Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA
Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535
[TBL] [Abstract][Full Text] [Related]
11. Serum and saliva concentrations of sulfamethoxazole and trimethoprim in adults and children: relation between saliva concentrations and in vitro activity against nasopharyngeal pathogens.
Kamme C; Melander A; Nilsson NI
Scand J Infect Dis; 1983; 15(1):107-13. PubMed ID: 6342125
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.
Wüst J; Wilkins TD
Antimicrob Agents Chemother; 1978 Sep; 14(3):384-90. PubMed ID: 708016
[TBL] [Abstract][Full Text] [Related]
13. Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria.
Liu T; Wang B; Guo J; Zhou Y; Julius M; Njire M; Cao Y; Wu T; Liu Z; Wang C; Xu Y; Zhang T
J Microbiol Biotechnol; 2015 Sep; 25(9):1559-67. PubMed ID: 25907064
[TBL] [Abstract][Full Text] [Related]
14. Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.
Bergeron MG; Simard P; Provencher P
J Clin Microbiol; 1987 Apr; 25(4):650-5. PubMed ID: 3494745
[TBL] [Abstract][Full Text] [Related]
15. Agar dilution susceptibility of Bacteroides spp. to sulfamethoxazole and trimethoprim: correlation with a disk diffusion technique.
Riley TV
Antimicrob Agents Chemother; 1981 Dec; 20(6):731-5. PubMed ID: 7325639
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group.
Sutter VL; Kwok YY
Antimicrob Agents Chemother; 1981 Dec; 20(6):723-5. PubMed ID: 6459765
[TBL] [Abstract][Full Text] [Related]
17. Regression-line analysis of trimethoprim-sulfamethoxazole activity against Neisseria gonorrhoeae.
Prior RB; Fass RJ; Perkins RL
Am J Clin Pathol; 1976 Sep; 66(3):605-9. PubMed ID: 822707
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro susceptibility of Neisseria gonorrhoeae to trimethoprim-sulfamethoxazole on three different media.
Yoshikawa TT; Miyamoto S; Guze LB
Antimicrob Agents Chemother; 1975 Nov; 8(5):515-7. PubMed ID: 813569
[TBL] [Abstract][Full Text] [Related]
19. Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.
Fuchs PC; Barry AL; Brown SD
J Clin Microbiol; 1997 Jan; 35(1):125-31. PubMed ID: 8968893
[TBL] [Abstract][Full Text] [Related]
20. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.
Guerrant RL; Wood SJ; Krongaard L; Reid RA; Hodge RH
Antimicrob Agents Chemother; 1981 Jan; 19(1):33-8. PubMed ID: 7247360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
